glp 1 drugs anti inflammatory Anti-inflammatory properties of GLP-1 receptor agonists and other ancillary benefits from a pharmacological perspective Glucagon-like peptide-1: a multi-faceted anti-inflammatory
Description
Mol Metab (2019) 30:72130
Average body weight dropped by 9.21 kg in the semaglutide group, while placebo patients showed minimal change
Noom + GLP-1 than with medication alone
The vision complications are rare, and more research needs to be done. NAION is a very rare side effect of semaglutide (Ozempic), affecting up to 1 in 10,000 patients, according to the report
Combination antithrombotic therapy, including GLP-1 receptor agonists, further exacerbates this risk [142]
